IRIS
LOPETUSO, Loris Riccardo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.359
EU - Europa 1.254
AS - Asia 254
AF - Africa 9
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 3
SA - Sud America 3
Totale 3.887
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.340
IE - Irlanda 476
IT - Italia 284
SE - Svezia 263
RU - Federazione Russa 102
VN - Vietnam 93
SG - Singapore 75
DE - Germania 20
GB - Regno Unito 18
IN - India 18
CA - Canada 16
BE - Belgio 15
CN - Cina 15
TW - Taiwan 15
RO - Romania 11
IR - Iran 10
FR - Francia 8
PL - Polonia 8
TH - Thailandia 7
BG - Bulgaria 6
HK - Hong Kong 6
EU - Europa 5
HR - Croazia 5
LU - Lussemburgo 5
UA - Ucraina 5
CH - Svizzera 4
JP - Giappone 4
MY - Malesia 4
AT - Austria 3
AU - Australia 3
DK - Danimarca 3
EG - Egitto 3
ES - Italia 3
FI - Finlandia 3
AR - Argentina 2
IQ - Iraq 2
LT - Lituania 2
ME - Montenegro 2
MX - Messico 2
NL - Olanda 2
NO - Norvegia 2
SA - Arabia Saudita 2
SC - Seychelles 2
ZA - Sudafrica 2
BN - Brunei Darussalam 1
HU - Ungheria 1
IM - Isola di Man 1
KR - Corea 1
MT - Malta 1
NG - Nigeria 1
PA - Panama 1
RS - Serbia 1
TN - Tunisia 1
TR - Turchia 1
VE - Venezuela 1
Totale 3.887
Salva come PNG Salva come JPEG
Città #
Chandler 766
Dublin 476
Princeton 234
Jacksonville 190
Ashburn 168
Altamura 114
Dong Ket 93
Wilmington 85
Ann Arbor 57
Singapore 45
Chieti 42
Falls Church 27
Rome 23
Taranto 19
Norwalk 17
Teramo 16
Brussels 15
London 12
Pune 12
Los Angeles 11
New York 11
Xitun 11
Edinburgh 9
Washington 8
Moscow 7
Cluj-Napoca 6
Guglionesi 6
Sofia 6
Tehran 6
Bologna 5
Chiang Mai 5
Chicago 5
Dallas 5
San Jose 5
Seattle 5
Woodbridge 5
Bari 4
Kuala Lumpur 4
Milan 4
Stockholm 4
Tokyo 4
Toronto 4
Copenhagen 3
Frankfurt am Main 3
Hangzhou 3
Hefei 3
Luxembourg 3
Montale 3
Taipei 3
Termoli 3
Zagreb 3
Zurich 3
Alexander 2
Amsterdam 2
Andover 2
Atlanta 2
Baghdad 2
Bengaluru 2
Boardman 2
Cairo 2
Central 2
Cologne 2
Corvallis 2
Croydon 2
Fairfield 2
Greccio 2
Hamburg 2
Helsinki 2
Hong Kong 2
Houston 2
Jeddah 2
Johannesburg 2
La Plata 2
Madrid 2
Maranello 2
Mountain View 2
Nanning 2
Oslo 2
Passaic 2
Podgorica 2
Querétaro City 2
Rijeka 2
Scorrano 2
Vilnius 2
Warsaw 2
Alba Iulia 1
Asyut 1
Bandar Seri Begawan 1
Bang Phlat 1
Bangkok 1
Belgrade 1
Berlin 1
Bilbao 1
Birmingham 1
Brescia 1
Brisbane 1
Brookfield 1
Bucharest 1
Budapest 1
Caserta 1
Totale 2.662
Salva come PNG Salva come JPEG
Nome #
13C-octanoic acid breath test to study gastric emptying time 85
Assessment of crohn’s disease activity: Magnetic resonance enterography in comparison with clinical and endoscopic evaluations 81
Gut Microbiota: A Key Modulator of Intestinal Healing in Inflammatory Bowel Disease 79
Anti-tumor necrosis factor α therapy associates to type 17 helper T lymphocytes immunological shift and significant microbial changes in dextran sodium sulphate colitis 77
Akkermansia muciniphila: Key player in metabolic and gastrointestinal disorders 62
Gemelli decision tree Algorithm to Predict the need for home monitoring or hospitalization of confirmed and unconfirmed COVID-19 patients (GAP-Covid19): Preliminary results from a retrospective cohort study 60
Specific 13C functional pathways as diagnostic targets in gastroenterology breath-tests: tricks for a correct interpretation 58
Bacillus clausii and gut homeostasis: state of the art and future perspectives 55
Characterization of sarcopenia in an IBD population attending an Italian gastroenterology tertiary center 54
Tricks for interpreting and making a good report on hydrogen and 13C breath tests 53
The gastrointestinal microbiome - Functional interference between stomach and intestine 51
Commensal Clostridia: Leading players in the maintenance of gut homeostasis 51
Nutrition and IBD: Malnutrition and/or Sarcopenia? A Practical Guide 50
Proteobacteria: A common factor in human diseases 49
Towards a disease-associated common trait of gut microbiota dysbiosis: The pivotal role of Akkermansia muciniphila 49
Role of yeasts in healthy and impaired gut microbiota: The gut mycome 49
Food components and dietary habits: Keys for a healthy gut microbiota composition 49
Ulcerative colitis 48
Gut microbiota and inflammatory bowel disease: So far so gut! 48
High dose amoxicillin-based first line regimen is equivalent to sequential therapy in the eradication of H. Pylori infection 48
Bacillus clausii for the treatment of acute diarrhea in children: A systematic review and meta-analysis of randomized controlled trials 47
Role of Helicobacter pylori infection on nutrition and metabolism 47
Esophageal microbiome signature in patients with Barrett’s esophagus and esophageal adenocarcinoma 46
European Crohn's and colitis organisation topical review on treatment withdrawal ['exit strategies'] in inflammatory bowel disease 46
Direct effect of infliximab on intestinal mucosa sustains mucosal healing: Exploring new mechanisms of action 45
Gut microbiota compositional and functional fingerprint in patients with alcohol use disorder and alcohol-associated liver disease 45
Gut microbiota profiling and gut-brain crosstalk in children affected by pediatric acute-onset neuropsychiatric syndrome and pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections 45
Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises from a First Meta-Analysis 45
Commentary to “safety, clinical response, and microbiome findings following fecal microbiota transplant in children with inflammatory bowel disease” 44
Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab 44
Locally injected Infliximab ameliorates murine DSS colitis: Differences in serum and intestinal levels of drug between healthy and colitic mice 44
Flexible colonoscopy in mice to evaluate the severity of colitis and colorectal tumors using a validated endoscopic scoring system 44
Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders 44
Dietary magnesium alleviates experimental murine colitis through upregulation of the transient receptor potential melastatin 6 channel 44
The innate and adaptive immune system as targets for biologic therapies in inflammatory bowel disease 44
Prevalence of cervical HPV and attitude towards cervical screening in IBD patients under immunomodulatory treatment: A multidisciplinary management experience 43
Gut microbiota modulation and mucosal immunity: Focus on Rifaximin 43
Gut Virome and Inflammatory Bowel Disease 43
Microbiota and inflammatory bowel disease: An update 43
IL-33 promotes recovery from acute colitis by inducing miR-320 to stimulate epithelial restitution and repair 43
Bacteriocins and bacteriophages: Therapeutic weapons for gastrointestinal diseases? 43
Opposing functions of classic and novel IL-1 family members in gut health and disease 42
Nodular lymphoid hyperplasia: A marker of low-grade inflammation in irritable bowel syndrome? 42
Actinobacteria: A relevant minority for the maintenance of gut homeostasis 41
Infliximab does not increase colonic cancer risk associated to murine chronic colitis 41
The gut barrier: New acquisitions and therapeutic approaches 40
Liver Injury, Endotoxemia, and Their Relationship to Intestinal Microbiota Composition in Alcohol-Preferring Rats 40
Pre- and posttherapy assessment of intestinal soluble mediators in IBD: Where we stand and future perspectives 40
Gelatin tannate and tyndallized probiotics: a novel approach for treatment of diarrhea 40
The Thrilling Journey of SARS-CoV-2 into the Intestine: From Pathogenesis to Future Clinical Implications 40
Intestinal permeability in physiological and pathological conditions: Major determinants and assessment modalities 39
Human herpesvirus 8-associated colonic Kaposi's sarcoma during vedolizumab treatment in ulcerative colitis: A case report and review of the literature 39
Epidemiology of inflammatory bowel disease in the Republic of San Marino: The “EPIMICI – San Marino” study 39
Considering gut microbiota disturbance in the management of Helicobacter pylori infection 39
Characterization of mucosal cytokine profile in ulcerative colitis patients under conventional and anti-TNF-a treatment 39
Relationship between oral microbiota and periodontal disease: A systematic review 38
Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection—single versus multiple infusions 38
Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre 38
The Role of Antibiotics in Gut Microbiota Modulation: The Eubiotic Effects of Rifaximin 38
Prevalence of severe irritable bowel syndrome among Italian adults. A meta-analysis 37
Epidemiological evaluation of acute gastroenteritis and therapeutic approaches in Middle East Countries 37
Microparticles produced by activated platelets carry a potent and functionally active angiogenic signal in subjects with crohn’s disease 37
The “dica” endoscopic classification for diverticular disease of the colon shows a significant interobserver agreement among community endoscopists 36
Gelatin tannate ameliorates acute colitis in mice by reinforcing mucus layer and modulating gut microbiota composition: Emerging role for ‘gut barrier protectors’ in IBD? 36
Fighting the Hype for Predictors of Efficacy in Inflammatory Bowel Disease 36
Coeliac disease under a microscope: Histological diagnostic features and confounding factors 35
Epithelial-specific Toll-like Receptor (TLR)5 Activation Mediates Barrier Dysfunction in Experimental Ileitis 34
The therapeutic management of gut barrier leaking: The emerging role for mucosal barrier protectors 34
A modern multidisciplinary approach to the treatment of enterocutaneous fistulas in Crohn’s disease patients 34
Beyond the HLA Genes in Gluten-Related Disorders 34
Effect of rifaximin on gut microbiota composition in advanced liver disease and its complications 34
Intestinal gas production and gastrointestinal symptoms: from pathogenesis to clinical implication 33
A novel model of colitis-associated cancer in SAMP1/YitFc mice with Crohn's disease-like ileitis 33
Fecal transplantation for ulcerative colitis: current evidence and future applications 33
Exploring Bacteroidetes: Metabolic key points and immunological tricks of our gut commensals 33
Can we predict the efficacy of anti-TNF-α agents? 33
Anti-TNF-α-induced psoriasiform lesions in IBD: An abnormal immune activation or a 'patchy cutaneous' immune suppression? 33
Microbes and Alzheimer' disease: Lessons from H. Pylori and GUT microbiota 32
Assessment of neurological manifestations in hospitalized patients with COVID-19 32
Emerging role of the interleukin (IL)-33/ST2 axis in gut mucosal wound healing and fibrosis 32
Changes in admissions, and hospitalization outcomes of IBD patients in an Italian tertiary referral center over a 13-year period 32
Role and mechanisms of action of Escherichia coli nissle 1917 in the maintenance of remission in ulcerative colitis patients: an update 31
The use of anti-spasmodics in the treatment of irritable bowel syndrome: Focus on otilonium bromide 31
Bariatric procedures and microbiota: patient selection and outcome prediction 31
The impact of COVID-19 pandemic on IBD endoscopic procedures in a high-volume IBD Center 30
Rifaximin for the treatment of irritable bowel syndrome – a drug safety evaluation 29
Skeletal muscle-gut axis: Emerging mechanisms of sarcopenia for intestinal and extra intestinal diseases 28
The use of probiotics in different phases of diverticular disease 27
International consensus conference on stool banking for faecal microbiota transplantation in clinical practice 27
A transition clinic model for inflammatory bowel disease between two tertiary care centers: outcomes and predictive factors 27
Gut microbial flora, prebiotics, and probiotics in IBD: Their current usage and utility 27
Novel trends with biologics in inflammatory bowel disease: sequential and combined approaches 25
The intriguing role of Rifaximin in gut barrier chronic inflammation and in the treatment of Crohn’s disease 24
Harmful effects and potential benefits of anti-tumor necrosis factor (TNF)-α on the liver 24
Increased Faecalibacterium abundance is associated with clinical improvement in patients receiving rifaximin treatment 23
Inflammatory Bowel Disease Patients With Coronavirus Disease 2019: The Picture Is Taking Shape 21
Gut microbiota during dietary restrictions: New insights in non-communicable diseases 20
How to face the advent of sars-cov-2 vaccination in ibd patients: Another task for gastroenterologists 20
European guideline on indications, performance, and clinical impact of hydrogen and methane breath tests in adult and pediatric patients: European Association for Gastroenterology, Endoscopy and Nutrition, European Society of Neurogastroenterology and Motility, and European Society for Paediatric Gastroenterology Hepatology and Nutrition consensus 19
Faecal microbiota transplantation for the treatment of diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma 18
Totale 4.033
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.334
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.334
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021782 235 4 165 34 59 135 12 10 10 6 16 96
2021/2022705 53 3 3 118 20 16 11 28 54 39 60 300
2022/20231.882 241 337 89 224 95 348 120 143 169 18 81 17
2023/2024849 53 36 47 51 36 186 235 87 14 37 13 54
2024/2025145 145 0 0 0 0 0 0 0 0 0 0 0
Totale 4.363